> SIFI COMPLETES ENROLLMENT OF THE PHASE III STUDY OF POLIHEXANIDE 0.08% FOR THE TREATMENT OF ACANTHAMOEBA KERATITIS
 
 
Welcome to our Press Release section. In this area you will find official announcements and statements directed to the press. For any inquiries regarding these Press Releases and ongoing pre...
Follow Us!